MRK Stock Forecast 2024: Merck & Co Inc (NYSE: MRK) Remains Strong With -159.17% Downside

In the last trading session, 1.13 million Merck & Co Inc (NYSE:MRK) shares changed hands as the company’s beta touched 0.40. With the company’s per share price at $113.44 changed hands at -$1.3 or -1.13% during last session, the market valuation stood at $287.56B. MRK’s last price was a discount, traded about -18.68% off its 52-week high of $134.63. The share price had its 52-week low at $99.14, which suggests the last value was 12.61% up since then. When we look at Merck & Co Inc’s average trading volume, we note the 10-day average is 10.84 million shares, with the 3-month average coming to 9.17 million.

Analysts gave the Merck & Co Inc (MRK) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.48. If we narrow down to specifics, the data shows that 0 out of 19 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended MRK as a Hold, 19 felt it is a Buy and 0 rated the stock as Underweight.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Merck & Co Inc (NYSE:MRK) trade information

Instantly MRK was in red as seen at the end of in last trading. With action -1.12%, the performance over the past five days has been red. The company’s shares are showing year-to-date upside of 4.06%, with the 5-day performance at -1.12% in the red. However, in the 30-day time frame, Merck & Co Inc (NYSE:MRK) is -2.69% down. Looking at the short shares, we see there were 24.81 million shares sold at short interest cover period of 2.91 days.

The consensus price target for the stock as assigned by Wall Street analysts is 120, meaning bulls need an upside of 5.47% from its current market value. According to analyst projections, MRK’s forecast low is 80 with 294 as the target high. To hit the forecast high, the stock’s price needs a -159.17% plunge from its current level, while the stock would need to tank 29.48% for it to hit the projected low.

Merck & Co Inc (MRK) estimates and forecasts

Data shows that the Merck & Co Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -12.67% over the past 6 months, a 430.46% in annual growth rate that is considerably higher than the industry average of 6.20%.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -42.70%. The 2024 estimates are for Merck & Co Inc earnings to increase by 431.20%.

MRK Dividends

Merck & Co Inc is expected to release its next quarterly earnings report on 2024-Oct-31. The 2.72% annual yield figure for the share gives it an annual dividend of 3.08. It is important to note, however, that the 2.72% dividend yield ratio should serve as a guide only, as you should also take into consideration many other aspects of a company’s operations and fundamentals before making any investment decision. During the past 5 years, the average dividend yield was 2.89 per year.

Merck & Co Inc (NYSE:MRK)’s Major holders

If we look at who the major shareholders are, we find that insiders hold 0.06% of Merck & Co Inc shares while 79.05% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 79.09%. There are 79.05% institutions holding the Merck & Co Inc stock share, with VANGUARD GROUP INC the top institutional holder. As of 2024-06-30, the company held 9.6596% of the shares, roughly 244.68 million MRK shares worth $30.29 billion.

BLACKROCK INC. holds the second largest percentage of outstanding shares, with 8.1838% or 207.3 million shares worth $25.66 billion as of 2024-06-30.